Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,445.60
(
-0.74%
)
US TECH 100
28,548.00
(
-0.85%
)
Dow Jones
49,625.31
(
-0.88%
)
Brent Oil
106.53
(
2.25%
)
Bitcoin
79,409.93
(
-2.03%
)
News Focus
News Focus
Post# of 257575
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Spitz

Send PM Follow Ignore
Followers 0
Posts 5
Boards Moderated 0
Alias Born 02/05/2006

Spitz

Re: DewDiligence post# 55895

Monday, 12/10/2007 10:17:33 AM

Monday, December 10, 2007 10:17:33 AM

Post# of 257575
Both Factor Xa inhibitors are also being tested in ACS. They are both in Phase II. For example, apixaban:

http://clinicaltrials.gov/show/NCT00313300

Also, Dabigatran RE-DEEM trial is 6 month treatment. I assume that Momenta's drug is in hospital treatment since it is IV - so do you consider the two drugs competitors?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today